Free Trial

The Manufacturers Life Insurance Company Lowers Position in Option Care Health, Inc. (NASDAQ:OPCH)

Option Care Health logo with Medical background

The Manufacturers Life Insurance Company cut its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 13.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,517,992 shares of the company's stock after selling 233,416 shares during the quarter. The Manufacturers Life Insurance Company owned about 0.89% of Option Care Health worth $35,217,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Murphy & Mullick Capital Management Corp bought a new stake in Option Care Health in the 4th quarter valued at $26,000. UMB Bank n.a. lifted its stake in Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after purchasing an additional 346 shares during the last quarter. Signaturefd LLC boosted its position in shares of Option Care Health by 487.9% during the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after buying an additional 1,005 shares during the period. Quadrant Capital Group LLC grew its stake in shares of Option Care Health by 172.8% during the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock valued at $40,000 after buying an additional 1,099 shares during the last quarter. Finally, Johnson Financial Group Inc. bought a new position in shares of Option Care Health during the fourth quarter valued at approximately $47,000. Institutional investors own 98.05% of the company's stock.

Insider Activity at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.64% of the stock is currently owned by insiders.

Analyst Ratings Changes

OPCH has been the topic of a number of research reports. Jefferies Financial Group raised shares of Option Care Health from a "hold" rating to a "buy" rating and raised their target price for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their price objective for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. JMP Securities reiterated a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a research note on Tuesday, April 22nd. Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. Finally, JPMorgan Chase & Co. boosted their price objective on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research report on Thursday, March 6th. One analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $35.50.

Read Our Latest Stock Analysis on OPCH

Option Care Health Stock Up 0.1 %

Shares of NASDAQ OPCH traded up $0.03 during mid-day trading on Wednesday, reaching $32.77. The company had a trading volume of 301,763 shares, compared to its average volume of 1,825,146. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The company has a market capitalization of $5.37 billion, a price-to-earnings ratio of 27.54, a PEG ratio of 2.30 and a beta of 0.76. The stock has a fifty day moving average of $33.33 and a two-hundred day moving average of $28.85. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.04. The company had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.26 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The company's quarterly revenue was up 16.3% on a year-over-year basis. During the same period in the previous year, the business earned $0.26 earnings per share. As a group, equities research analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current year.

About Option Care Health

(Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Read More

Institutional Ownership by Quarter for Option Care Health (NASDAQ:OPCH)

Should You Invest $1,000 in Option Care Health Right Now?

Before you consider Option Care Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.

While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines